Elsevier

The Lancet

Volume 353, Issue 9170, 19 June 1999, Pages 2116-2119
The Lancet

Articles
Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in the Netherlands: a cohort study

https://doi.org/10.1016/S0140-6736(98)10028-4Get rights and content

Section snippets

Background

Carriers of Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) may show muscle weakness or dilated cardiomyopathy. Studies focusing on skeletal-muscle involvement were done before DNA analysis was possible. We undertook a cross-sectional study in a population of definite carriers to estimate the proportion and to assess the clinical profile of carriers with symptoms. We also assessed a possible correlation between genotype and phenotype.

Methods

Carriers of DMD and BMD, aged 18–60

Patients

Carriers of DMD and BMD were traced through the files at the Department of Human Genetics, University of Leiden, where registration of all familes affected by DMD and BMD has been kept since 1982. Carriers were considered to be definite when: they were found to be obligate carriers after pedigree analysis (definite X-linked inheritance); when a mutation in the dystrophin gene was found; or when linkage analysis revealed a chance of more than 99% for carriership.21, 22 Furthermore, when linkage

Results

A list of 275 names of definite carriers (198 DMD, 77 BMD) aged 18–60 years was extracted from the files of the Department of Human Genetics, Leiden. Seven carriers had died or were too ill to be included, leaving 268 names (193 DMD, 75 BMD). For 16 carriers (14 DMD, two BMD) no address could be found, and 28 carriers (26 DMD, two BMD) were not invited for logistical reasons. A total of 224 letters (153 DMD, 71 BMD) were sent out. 44 carriers (31 DMD, 13 BMD) did not respond to the invitation

Discussion

In this study we tried to include as many carriers within each family as possible to keep ascertainment bias to a minimum. However, we had no information about the carriers who did not respond to our invitation and only occasional information about the women who refused to participate. A selection bias may therefore have occurred towards carriers who had complaints and who wanted confirmation of their complaints by means of our study. On the other hand, eight (36%) carriers with muscle weakness

First page preview

First page preview
Click to open first page preview

References (33)

  • H Moser

    Biochemische, histologische und klinische befunde bei einer vierjahrigen Konduktorin der gutartigen X-chromosomalen Muskeldystrophie (Typ Becker)

    Hum Genet

    (1971)
  • K Haginoya et al.

    Dystrophin immunohistochemistry in a symptomatic carrier of Becker muscular dystrophy

    J Neurol

    (1991)
  • IA Glass et al.

    Investigation of a female manifesting Becker muscular dystrophy

    J Med Genet

    (1992)
  • Y Boyd et al.

    Muscular dystrophy in girls with X;autosomal translocations

    J Med Genet

    (1986)
  • CS Richards et al.

    Skewed X inactivation in a female MZ twin in Duchenne muscular dystrophy

    Am J Hum Genet

    (1990)
  • N Abbadi et al.

    Additional case of female monozygotic twins discordant for the clinical manifestations of Duchenne muscular dystrophy due to opposite X-chromosome inactivation

    Am J Med Genet

    (1994)
  • Cited by (204)

    • Treatment and Management of Muscular Dystrophies

      2021, Neuromuscular Disorders: Treatment and Management
    View all citing articles on Scopus
    View full text